167 related articles for article (PubMed ID: 30258519)
1. Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer.
Lyon PC; Winter H; Herbschleb K; Campo L; Carlisle R; Wu F; Goldin R; Coussios CC; Middleton MR; Gleeson FV; Boardman P; Sharma RA
Radiol Case Rep; 2018 Dec; 13(6):1259-1266. PubMed ID: 30258519
[TBL] [Abstract][Full Text] [Related]
2. Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review.
Baltatzis M; Siriwardena AK
Dig Surg; 2019; 36(4):273-280. PubMed ID: 29886488
[TBL] [Abstract][Full Text] [Related]
3. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.
Stubbs RS; Cannan RJ; Mitchell AW
J Gastrointest Surg; 2001; 5(3):294-302. PubMed ID: 11360053
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres.
Bhooshan N; Sharma NK; Badiyan S; Kaiser A; Moeslein FM; Kwok Y; Amin PP; Kudryasheva S; Chuong MD
J Gastrointest Oncol; 2016 Dec; 7(6):931-937. PubMed ID: 28078116
[TBL] [Abstract][Full Text] [Related]
5. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA;
BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708
[TBL] [Abstract][Full Text] [Related]
6. Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology.
Lu S; Dhillon J; Johnson JH; El-Haddad G
EJNMMI Res; 2021 Feb; 11(1):17. PubMed ID: 33604708
[TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 radioembolization of hepatic metastases from colorectal cancer.
Raval M; Bande D; Pillai AK; Blaszkowsky LS; Ganguli S; Beg MS; Kalva SP
Front Oncol; 2014; 4():120. PubMed ID: 25120951
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
9. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.
Kuei A; Saab S; Cho SK; Kee ST; Lee EW
World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079
[TBL] [Abstract][Full Text] [Related]
10. Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases.
O'Leary C; Greally M; McCaffrey J; Hughes P; Lawler LLP; O'Connell M; Geoghegan T; Farrelly C
Ir J Med Sci; 2019 Feb; 188(1):43-53. PubMed ID: 29511912
[TBL] [Abstract][Full Text] [Related]
11. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.
Pardo F; Sangro B; Lee RC; Manas D; Jeyarajah R; Donckier V; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Masi G; Fisher KT; Lau WY; Kouladouros K; Katsanos G; Ercolani G; Rotellar F; Bilbao JI; Schoen M
Ann Surg Oncol; 2017 Sep; 24(9):2465-2473. PubMed ID: 28653161
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible?
Hoffmann RT; Jakobs TF; Kubisch CH; Stemmler HJ; Trumm C; Tatsch K; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Apr; 74(1):199-205. PubMed ID: 19269763
[TBL] [Abstract][Full Text] [Related]
13. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.
Xing M; Prajapati HJ; Dhanasekaran R; Lawson DH; Kokabi N; Eaton BR; Kim HS
Am J Clin Oncol; 2017 Feb; 40(1):27-34. PubMed ID: 25089529
[TBL] [Abstract][Full Text] [Related]
14. Regorafenib Prior to Selective Internal Radiation Therapy Using
Kennedy A; Shipley D; Shpak M; Blakely L; Hemphill B; Shih K; Lane C; Zimmerman L; McKenzie A; Mainwaring M; Peyton JD; Zubkus J; Wright D; Singh J; Bendell JC
Front Oncol; 2019; 9():624. PubMed ID: 31355141
[No Abstract] [Full Text] [Related]
15. Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer.
Cortesi E; Caponnetto S; Masi G; Urbano F; Mezi S; Gelibter A; Pelle G; Filippi L; Cianni R
Clin Colorectal Cancer; 2020 Dec; 19(4):e272-e276. PubMed ID: 32768271
[TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D
Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569
[TBL] [Abstract][Full Text] [Related]
17. A descriptive analysis of the characteristics, treatment response and prognosis of hepatic dominant solid tumors undergoing selective internal radiation therapy (SIRT).
Gosztonyi B; Pestalozzi B; Kenkel D; Engel-Bicik I; Kaufmann PA; Treyer V; Siebenhüner AR
J Gastrointest Oncol; 2022 Dec; 13(6):3240-3253. PubMed ID: 36636090
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
19. Selective internal radiation therapy for liver metastases from colorectal cancer.
Townsend A; Price T; Karapetis C
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007045. PubMed ID: 19821394
[TBL] [Abstract][Full Text] [Related]
20. Liver Metastases in Pancreatic Acinar Cell Carcinoma Treated with Selective Internal Radiation Therapy with Y-90 Resin Microspheres.
Nasser F; Motta Leal Filho JM; Affonso BB; Galastri FL; Cavalcante RN; Martins DLN; Segatelli V; Yamaga LYI; Gansl RC; Tranchesi Junior B; Macedo ALV
Case Reports Hepatol; 2017; 2017():1847428. PubMed ID: 29158927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
